Merck Animal Health

From DolceraWiki
Jump to: navigation, search

Go back to homepage


Merck Animal Health
Financial Details
Total Company Revenue in 2010 $ 46 Bn
Revenue from Animal Health Market in 2010 $ 2.9 Bn
% of revenue from Animal Health in 2010 6.30%
Segmentwise Revenue Breakup ($ Bn)
Livestock Vaccines 2.233
Companion Vaccines 0.667
Number of Major Vaccines (Animal-wise)
Poultry 3
Swine 1
Fish 1
Sheep 1
Cattle 3
Canine 1
Feline 1
Equine 2
Mergers and Acquisitions (2009 - 2011) Consideration
Schering-Plough $ 41 Bn
Future Focus Areas
Veterinary Vaccines under trial 0
Future Focus Areas of the company in the Veterinary Vaccines Market Viral and parasitological vaccines
In pharmaceutical R&D, Merck has 120 ongoing projects focusing on parasiticides, anti-infectives and internal medicine (endocrine/pain) and performance products.
In biological R&D, Merck has 140 projects in progress focusing on zoonotic and emerging diseases, respiratory diseases, enteric diseases and enabling technologies.




Go back to homepage